Neurogait is developing AI based clinical screenings for neurodegenerative Disease including curable dementia, Parkinson's
It is currently conducting clinical pilots in Germany and is integrating its solution under a commercial agreement with a large on-line European patient platform. It is also working on its regulatory approvals.